| 4627- | OLE, | Oleuropein regulates ubiquitination-mediated Mcl-1 turnover and exhibits antitumor activity |
| - | in-vitro, | Oral, | NA |
| 4626- | OLE, | A Comprehensive Review on the Anti-Cancer Effects of Oleuropein |
| - | Review, | Var, | NA |
| 4631- | OLE, | Evidence to Support the Anti-Cancer Effect of Olive Leaf Extract and Future Directions |
| - | Review, | Var, | NA |
| 4649- | OLEC, | Anticancer molecular mechanisms of oleocanthal |
| 4646- | OLEC, | Oleocanthal as a Multifunctional Anti-Cancer Agent: Mechanistic Insights, Advanced Delivery Strategies, and Synergies for Precision Oncology |
| - | Review, | Var, | NA |
| 4647- | OLEC, | Oleocanthal, an Antioxidant Phenolic Compound in Extra Virgin Olive Oil (EVOO): A Comprehensive Systematic Review of Its Potential in Inflammation and Cancer |
| - | Review, | Var, | NA |
| 4648- | OLEC, | The Effect of Dietary Intervention With High-Oleocanthal and Oleacein Olive Oil in Patients With Early-Stage Chronic Lymphocytic Leukemia: A Pilot Randomized Trial |
| - | Trial, | CLL, | NA |
| 7532- | Olive Oil, | HT, | OLE, | Impact of Olive Oil Fatty Acids and Bioactive Compounds on Cognitive Function in Adults: A Systematic Review |
| - | Review, | AD, | NA |
| 1225- | OLST, | Orlistat Induces Ferroptosis in Pancreatic Neuroendocrine Tumors by Inactivating the MAPK Pathway |
| - | vitro+vivo, | PC, | NA |
| 1228- | OLST, | Orlistat Mitigates Oxidative Stress-Linked Myocardial Damage via NF-κβ- and Caspase-Dependent Activities in Obese Rats |
| - | in-vivo, | Obesity, | NA |
| 1227- | OLST, | Anti-Obesity Drug Orlistat Alleviates Western-Diet-Driven Colitis-Associated Colon Cancer via Inhibition of STAT3 and NF-κB-Mediated Signaling |
| - | in-vivo, | CRC, | NA |
| 1226- | OLST, | Knockdown of PGM1 enhances anticancer effects of orlistat in gastric cancer under glucose deprivation |
| - | vitro+vivo, | GC, | NA |
| 1045- | OLST, | Fatty acid synthase inhibitor orlistat impairs cell growth and down-regulates PD-L1 expression of a human T-cell leukemia line |
| - | in-vitro, | AML, | Jurkat |
| 969- | OLST, | Orlistat as a FASN inhibitor and multitargeted agent for cancer therapy |
| - | Review, | NA, | NA |
| 8430- | OM, | T4O, | Exploring the Anticancer Potential of Origanum majorana Essential Oil Monoterpenes Alone and in Combination against Non-Small Cell Lung Cancer |
| - | vitro+vivo, | NSCLC, | A549 | - | in-vitro, | Lung, | LNM35 |
| 8428- | OM, | The antiproliferative effect of Origanum majorana on human hepatocarcinoma cell line: suppression of NF-κB |
| - | in-vitro, | HCC, | HepG2 |
| 8427- | OM, | Mitotic arrest and apoptosis in breast cancer cells induced by Origanum majorana extract: upregulation of TNF-α and downregulation of survivin and mutant p53 |
| - | in-vitro, | BC, | MDA-MB-231 |
| 8426- | OM, | Origanum majorana Ethanolic Extract Promotes Colorectal Cancer Cell Death by Triggering Abortive Autophagy and Activation of the Extrinsic Apoptotic Pathway |
| - | in-vitro, | CRC, | HT-29 | - | in-vitro, | Colon, | Caco-2 |
| 8425- | OM, | Anti-metastatic and anti-tumor growth effects of Origanum majorana on highly metastatic human breast cancer cells: inhibition of NFκB signaling and reduction of nitric oxide production |
| - | vitro+vivo, | BC, | MDA-MB-231 |
| 8424- | OM, | Origanum majorana Essential Oil Triggers p38 MAPK-Mediated Protective Autophagy, Apoptosis, and Caspase-Dependent Cleavage of P70S6K in Colorectal Cancer Cells |
| - | in-vitro, | CRC, | HT-29 |
| 8453- | OM, | Origanum majorana Attenuates Nephrotoxicity of Cisplatin Anticancer Drug through Ameliorating Oxidative Stress |
| - | in-vivo, | Nor, | NA |
| 8429- | OM, | Origanum majorana essential oil decreases lung tumor growth and metastasis in vitro and in vivo |
| - | vitro+vivo, | NSCLC, | A549 | - | in-vitro, | Lung, | LNM35 |
| 8431- | OM, | Effects of Origanum majorana on Breast Cancer Cells: An Alternative to Chemotherapy? |
| - | in-vitro, | BC, | MCF7 |
| 8432- | OM, | Cytotoxicity of the Aqueous Extract and Organic Fractions from Origanum majorana on Human Breast Cell Line MDA-MB-231 and Human Colon Cell Line HT-29 |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | CRC, | HT-29 |
| 8433- | OM, | Toxicological Assessment of Origanum majorana L.: Evaluation of Its Cytotoxicity, Genotoxicity, and Acute Oral Toxicity |
| - | in-vivo, | Nor, | NA |
| 8434- | OM, | Traditional use, phytochemistry, toxicology, and pharmacology of Origanum majorana L |
| - | Review, | Var, | NA |
| 8435- | OM, | Aroma, | Memory-Enhancing Effects of Origanum majorana Essential Oil in an Alzheimer's Amyloid beta1-42 Rat Model: A Molecular and Behavioral Study |
| - | in-vivo, | AD, | NA |
| 8436- | OM, | Origanum majorana L. protects against neuroinflammation-mediated cognitive impairment: a phyto-pharmacological study |
| - | in-vivo, | AD, | NA |
| 8437- | OM, | Neuroprotective Potential of Origanum majorana L. Essential Oil Against Scopolamine-Induced Memory Deficits and Oxidative Stress in a Zebrafish Model |
| - | in-vivo, | AD, | NA |
| 8438- | OM, | UA, | VitE, | Ursolic acid of Origanum majorana L. reduces Abeta-induced oxidative injury |
| - | in-vitro, | AD, | NA |
| 8440- | OM, | Free radical scavenging and antiacetylcholinesterase activities of Origanum majorana L. essential oil |
| - | in-vitro, | AD, | NA |
| 8441- | OM, | The effect of Origanum majorana tea on motor and non-motor symptoms in patients with idiopathic Parkinson's disease: A randomized controlled pilot study |
| - | Trial, | Park, | NA |
| 8442- | OM, | Marjoram Extract Modulates Ion Currents, Intracellular Calcium Signaling, and MTT-Reducing Activity in Bovine Chromaffin Cells and Rat Cortical Neurons |
| - | in-vitro, | Nor, | NA |
| 8443- | OM, | Natural Remedies for Gut Health: The Role of Plant Extracts in Combating Inflammatory Bowel Disease and Colon Cancer |
| - | Review, | IBD, | NA | - | Review, | Colon, | NA |
| 8445- | OM, | Exploring the therapeutic potential of marjoram (Origanum majorana L.) in polycystic ovary syndrome: insights from serum metabolomics, network pharmacology and experimental validation |
| - | in-vivo, | Nor, | NA |
| 8446- | OM, | Calcium Channel Inhibitory Effect of Marjoram (Origanum majorana L.): Its Medicinal Use in Diarrhea and Gut Hyperactivity |
| - | in-vivo, | Nor, | NA |
| 8447- | OM, | Inhalation of Origanum majorana L. essential oil while working reduces perceived stress and anxiety levels of nurses in a COVID-19 intensive care unit: a randomized controlled trial |
| - | Trial, | Nor, | NA |
| 8448- | OM, | Origanum majorana Essential Oil-A Review of Its Chemical Profile and Pesticide Activity |
| - | Review, | Nor, | NA |
| 8449- | OM, | Ethanolic extract of Origanum syriacum L. leaves exhibits potent anti-breast cancer potential and robust antioxidant properties |
| - | in-vitro, | BC, | MDA-MB-231 |
| 8450- | OM, | Can Origanum be a hope for cancer treatment? A review on the potential of Origanum species in preventing and treating cancers |
| - | Review, | Var, | NA |
| 8452- | OM, | Sweet Marjoram: A Review of Ethnopharmacology, Phytochemistry, and Biological Activities |
| - | Review, | Nor, | NA |
| 8454- | OM, | Aqueous Extract of Origanum majorana at Low Temperature (0°C) Promotes Mitochondrial Fusion and Contributes to Induced Apoptosis in Human Breast Cancer Cells |
| - | in-vitro, | BC, | NA |
| 8451- | Oreg, | A multi-parameter evaluation of the neuroprotective and cognitive-enhancing effects of Origanum onites L. (Turkish Oregano) essential oil on scopolamine-induced amnestic rats |
| - | in-vivo, | AD, | NA |
| 6766- | Oreg, | Chemical Composition, Biological Activity, and Potential Uses of Oregano (Origanum vulgare L.) and Oregano Essential Oil |
| - | Review, | Nor, | NA |
| 1811- | Oxy, | Hyperbaric oxygen therapy and cancer—a review |
| - | Review, | NA, | NA |
| 1812- | Oxy, | Hyperbaric oxygen suppressed tumor progression through the improvement of tumor hypoxia and induction of tumor apoptosis in A549-cell-transferred lung cancer |
| - | in-vitro, | Lung, | A549 | - | in-vivo, | Lung, | NA | - | in-vitro, | NA, | BEAS-2B |
| 1813- | Oxy, | Advances in hyperbaric oxygen to promote immunotherapy through modulation of the tumor microenvironment |
| - | Review, | Var, | NA |
| 1814- | Oxy, | Hyperbaric oxygen therapy for malignancy: a review |
| - | Review, | Var, | NA |
| 5937- | P, | Peppermint and the gut |
| - | Review, | IBD, | NA |
| 5936- | P, | The impact of peppermint oil on the irritable bowel syndrome: a meta-analysis of the pooled clinical data |
| - | Review, | IBD, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid